Satisfaction Assessment After Axillary Block

Overview

Satisfaction assessment at 24 and 48 hours post operatively, after Axillary Brachial Plexus Block for Distal Arm Surgery.

Full Title of Study: “Satisfaction Assessment After Axillary Brachial Plexus Block for Distal Arm Surgery”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: January 31, 2021

Detailed Description

Inclusion after distal Arm Surgery performed under Axillary Brachial Plexus Block. Satisfaction assessment at 24 and 48 hours post operatively by self-administered survey questionnaire based on different scales: Evan-LR, Net Promotor Score, Satisfaction score.

Interventions

  • Other: perioperative satisfaction assessment
    • Satisfaction assessment at 24 and 48 hours post operatively by self-administered survey questionnaire based on different scales: Evan-LR, Net Promotor Score, Satisfaction score.

Arms, Groups and Cohorts

  • Qual’AXI group
    • patients for whom distal arm surgery was performed under Axillary Brachial Plexus Block

Clinical Trial Outcome Measures

Primary Measures

  • Evan-LR score on day 2
    • Time Frame: at 48 hours postoperative
    • self administrated Evan-LR: “Evaluation du Vécu de l’Anesthésie LocoRégionale” 0-to-100 scale, with “100” indicating the best possible level of satisfaction and “0” the worst.

Secondary Measures

  • Evan-LR score on day 1
    • Time Frame: at 24 hours postoperative
    • self administrated Evan-LR: “Evaluation du Vécu de l’Anesthésie LocoRégionale” 0-to-100 scale, with “100” indicating the best possible level of satisfaction and “0” the worst.
  • Net Promotor score on day 2
    • Time Frame: at 48 hours postoperative
    • self administrated Net Promotor score: willingness to advise a relative to undergo the same operation on a scale from 0 to 10. Based on the score, patients are divided into promoters (9 or 10), passives (7 or 8), and detractors (under 6). The NPS is determined as follows: NPS = % promoters – % detractors
  • Net Promotor score on day 1
    • Time Frame: at 24 hours postoperative
    • self administrated Net Promotor score: willingness to advise a relative to undergo the same operation on a scale from 0 to 10. Based on the score, patients are divided into promoters (9 or 10), passives (7 or 8), and detractors (under 6). The NPS is determined as follows: NPS = % promoters – % detractors
  • Patient Satisfaction score on day 2
    • Time Frame: at 48 hours postoperative
    • self administrated Satisfaction score: scale from 0 to 10. A score of “0” meant extremely dissatisfied and that a score of “10” meant extremely satisfied
  • Patient Satisfaction score on day 1
    • Time Frame: at 24 hours postoperative
    • self administrated Satisfaction score: scale from 0 to 10. A score of “0” meant extremely dissatisfied and that a score of “10” meant extremely satisfied

Participating in This Clinical Trial

Inclusion Criteria

  • patients for whom distal arm surgery was performed under Axillary Brachial Plexus Block Exclusion Criteria:

  • Refusal, inability to consent – inability to fill self-administered survey questionnaire – pregnancy and breastfeeding – surgery > 2 hours – second surgical site requiring anaesthesia or analgesia – chronic use of analgesia (including opioids) or illegal drugs

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Centre Hospitalier Universitaire de Besancon
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Francis Berthier, MD, 0033381218980, f1berthier@CHU-besancon.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.